The effect of glycosyltransferase GnT-V in the development and progression of oral cancer and evaluation by PET.
Project/Area Number |
23792307
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Surgical dentistry
|
Research Institution | Hokkaido University |
Principal Investigator |
ONODERA Makiko 北海道大学, 大学院・歯学研究科, 専門研究員 (20443963)
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | GnT-V / PET / HIF-1 / 口腔がん / 糖鎖 / 低酸素 / HIF-1α |
Research Abstract |
The pattern and expression of cell surface sugar chains greatly alter during the carcinogenesis and play important role in tumor progression. To clarify the role of glycosyltrasferase GnT-V in cancer development we examined the expression of GnT-V in the oral cancer association with the PET scan. Both GnT-V mRNA and protein are strongly enhanced in oral cancer compared with normal oral mucosa tissue. In the group with high SUV on FDG-PET and FMISO-PET hypoxia imaging, GnT-V and HIF-1α had tendency to express higher. The expression and function of GnT-V may increase in hypoxia condition. By treatment the human oral squamous cell carcinoma cell line SAS with swainsonine, an inhibitor of N-glycan processing, cell motility was reduced significantly. These results showed that the glycosylation by GnT-V is associate with cell motility and invasion enhancement in oral cancer and related in oral cancer progression.
|
Report
(3 results)
Research Products
(4 results)